Mean changes versus dichotomous definitions of improvement

Statistical Methods in Medical Research

Volumn 16, Issue 1, 2007, Pages 7-12

  Anderson, Jennifer J ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL; DRUG RESPONSE; EFFECT SIZE; HUMAN; METHODOLOGY; OUTCOME ASSESSMENT; RHEUMATOID ARTHRITIS; SAMPLE SIZE; SIMULATION; STATISTICAL ANALYSIS;

ARTHRITIS, RHEUMATOID; CLINICAL TRIALS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); RESEARCH DESIGN; SPONDYLITIS, ANKYLOSING; UNITED STATES;

EID: 33847042607     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280206070651     Document Type: Article

References (13)

1. Food and Drug Administration. Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (Adults and Children). April 1988.
2. O'Brien PC. Procedures for comparing samples with multiple endpoints. Biometrics 1984; 40: 1079-87.
3. Felson DT, Anderson JJ and the ACR Committee on Outcome Measures in RA trials. American College of rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis and Rheumatism 1995; 38: 727-35.
4. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis and Rheumatism 2001; 44: 1876-86.
5. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, Paulus H, Tugwell P, Weinblatt M, Widmark R, Williams HJ, Wolfe F. The American College of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis and Rheumatism 1993; 35: 729-40.
6. Davies GM, Watson DJ, Bellamy N. Comparison of the responsiveness and relative effect size of the Western Ontario and McMaster Universities osteoarthritis index and the short-form medical outcomes study survey in a randomized clinical trial of osteoarthritis patients. Arthritis Care Research 1999; 12: 172-9.
7. Dionne CE, von Korff M, Koepsell TD, Deyo RA, Barlow WE, Checkoway H. A comparison of pain, functional limitations, and work status indices as outcome measures in back pain research. Spine 1999; 24: 2339-45.
8. Chernoff MC, Wang M, Anderson JJ, Felson DT. Problems and suggested solutions in creating an archive of clinical trials data to permit later meta-analysis: an example of methotrexate trials in rheumatoid arthritis. Controlled Clinical Trials 1995; 16: 342-55.
9. Anderson JJ, Bolognese JA, Felson DT. Comparison of rheumatoid arthritis clinical trial outcome measures: A simulation study. Arthritis and Rheumatism 2003; 48: 3031-8.
10. SAS MVN macro. Cary (NC): SAS Institute; 2000.
11. SAS software: release 8.2. Cary (NC): SAS Institute;1999.
12. van Tubergen A, van der Heijde D, Anderson JJ, Landewe R, Dougados M, Braun J, Bellamy N, Udrea G, van der Linden SJ, for the ASAS Working Group. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Annals of the Rheumatic Diseases 2003; 62: 215-21.
13. Cohen J. Statistical power analysis for the behavioral sciences, revised edition. Academic Press, 1977.